Charles River has added another string to its early-stage R&D bow by acquiring preclinical services firm Citoxlab for $510 million in cash.
The revolving door of FDA staffers into the life science industry continues as four former executives at the U.S. regulator join the CRO’s ranks.
The Canada-based units of Boehringer Ingelheim and IBM will work together to employ blockchain record-keeping technology in clinical trials.
Aetion closes on a $27 million extension of series B financing.
Moderna has opted to enter a licensing deal with U.K.-based Avacta Group to use the U.K.-based company’s Affimer biotherapeutics and reagents.
Welsh CRO Simbec-Orion was acquired by U.K.-based private equity firm CBPE Capital for an undisclosed price.
MMS Holdings, MIT Julia Lab and the University of Maryland form the Health Analytics Collective.
Abcam acquires California’s Calico Biolabs for an undisclosed price.
WIRB-Copernicus Group acquires Velos eResearch, a clinical trial management solutions provider, for an undisclosed price.
Icon adopted a new digital platform developed with Dimension Data.
